Jennifer K. Mulligan

University of Florida, USA

Title: What Can We Learn About Chronic Rhinosinusitis Through Mucus?

---

Biography

Jennifer Mulligan, PhD, is a pioneer in nasal mucus biomarker research for chronic rhinosinusitis (CRS). Her lab was the first to show that nasal mucus can serve as a surrogate for tissue biopsies and can track inflammatory changes in response to treatment. She later led the first multi?center study demonstrating reliable biomarker results across institutions, helping establish mucus sampling as a global research tool. At the University of Florida, Dr. Mulligan continues advancing mucus biomarker research. She currently serves as co-leader of an NIH?funded clinical trial to determine if differences in clinical outcomes can be seen across specific biologics in CRSwNP and that nasal mucus biomarkers can be used to identify patients most likely to improve on biologic therapy. Her work has been featured by the BBC and in leading scientific journals. 

Abstract